Nixon; Andrew
Patent Applications and Registrations
Patent applications and USPTO patent grants for Nixon; Andrew.The latest application filed is for "assays for determining plasma kallikrein system biomarkers".
Company Profile
13.15.35
- Nixon; Andrew - Hanover MA
- Nixon; Andrew - Durham NC
- NIXON; Andrew - Bristol GB
- Nixon; Andrew - Meerbusch DE
- Nixon, Andrew - Filton GB
Patent Activity
| Patent | Date |
|---|---|
| Assays For Determining Plasma Kallikrein System Biomarkers App 20220291232 - Sexton; Daniel J. ; et al. | 2022-09-15 |
| Bispecific antibodies against plasma kallikrein and Factor XII Grant 11,390,687 - Comeau , et al. July 19, 2 | 2022-07-19 |
| Assays for determining plasma kallikrein system biomarkers Grant 11,372,002 - Sexton , et al. June 28, 2 | 2022-06-28 |
| Evaluation And Treatment Of Bradykinin-mediated Disorders App 20220170936 - Sexton; Daniel J. ; et al. | 2022-06-02 |
| Anti-plasma kallikrein antibodies Grant 11,299,553 - Nixon , et al. April 12, 2 | 2022-04-12 |
| Compositions And Methods For Treatment Of Diabetic Macular Edema App 20220033521 - Conley; Gregory P. ; et al. | 2022-02-03 |
| Methods of determining levels of cleaved and/or intact kininogen Grant 11,156,612 - Sexton , et al. October 26, 2 | 2021-10-26 |
| Monoclonal Antibody Inhibitor Of Factor Xiia App 20210230299 - Mason; Shauna ; et al. | 2021-07-29 |
| Compositions and methods for treatment of diabetic macular edema Grant 11,046,785 - Conley , et al. June 29, 2 | 2021-06-29 |
| Compositions And Methods For The Depletion Of Cd117+ Cells App 20210162063 - Nixon; Andrew ; et al. | 2021-06-03 |
| Monoclonal antibody inhibitor of factor XIIA Grant 10,913,802 - Mason , et al. February 9, 2 | 2021-02-09 |
| Compositions And Methods For The Depletion Of Cells App 20200376134 - Nixon; Andrew ; et al. | 2020-12-03 |
| Diagnosis And Treatment Of Autoimmune Diseases App 20200371120 - Sexton; Daniel J. ; et al. | 2020-11-26 |
| Diagnosis and treatment of autoimmune diseases Grant 10,648,990 - Sexton , et al. | 2020-05-12 |
| Methods for the depletion of cells Grant 10,624,973 - Nixon , et al. | 2020-04-21 |
| Compositions And Methods For Treatment Of Diabetic Macular Edema App 20200115469 - Conley; Gregory P. ; et al. | 2020-04-16 |
| Compositions And Methods For The Depletion Of Cells App 20190328901 - NIXON; Andrew ; et al. | 2019-10-31 |
| Compositions and methods for treatment of diabetic macular edema Grant 10,428,158 - Conley , et al. October 1, 2 | 2019-10-01 |
| Methods of Predicting Responsiveness of a Cancer to a VEGF Targeting Agent and Methods of Prognosing and Treating Cancer App 20190204320 - Nixon; Andrew ; et al. | 2019-07-04 |
| Compositions And Methods For The Depletion Of Cells App 20190192682 - Nixon; Andrew ; et al. | 2019-06-27 |
| Anti-plasma Kallikrein Antibodies App 20190185580 - Nixon; Andrew ; et al. | 2019-06-20 |
| Post-processing Of Additive Layer Manufactured Part App 20190184643 - SCHNEIDER; Stephan ; et al. | 2019-06-20 |
| Compositions And Methods For The Depletion Of Cd117+ Cells App 20190134217 - Nixon; Andrew ; et al. | 2019-05-09 |
| Diagnosis And Treatment Of Autoimmune Diseases App 20190120862 - Sexton; Daniel J. ; et al. | 2019-04-25 |
| A Monoclonal Antibody Inhibitor Of Factor Xiia App 20190002584 - Mason; Shauna ; et al. | 2019-01-03 |
| Methods for the depletion of CD117+ cells Grant 10,111,966 - Nixon , et al. October 30, 2 | 2018-10-30 |
| Diagnosis and treatment of autoimmune diseases Grant 10,101,344 - Sexton , et al. October 16, 2 | 2018-10-16 |
| Bispecific Antibodies Against Plasma Kallikrein And Factor Xii App 20180118851 - Comeau; Stephen R. ; et al. | 2018-05-03 |
| Compositions And Methods For The Depletion Of Cd117+ Cells App 20170360954 - NIXON; Andrew ; et al. | 2017-12-21 |
| Assays For Determining Plasma Kallikrein System Biomarkers App 20160252527 - Sexton; Daniel J. ; et al. | 2016-09-01 |
| Diagnosis And Treatment Of Autoimmune Diseases App 20160252533 - Sexton; Daniel J. ; et al. | 2016-09-01 |
| Anti-plasma Kallikrein Antibodies App 20160017055 - NIXON; Andrew ; et al. | 2016-01-21 |
| Evaluation And Treatment Of Bradykinin-mediated Disorders App 20150362493 - Sexton; Daniel J. ; et al. | 2015-12-17 |
| Compositions And Methods For Treatment Of Diabetic Macular Edema App 20150274841 - Conley; Gregory P. ; et al. | 2015-10-01 |
| Hk1-binding Proteins App 20120027686 - Sexton; Daniel J. ; et al. | 2012-02-02 |
| HK1-binding proteins Grant 7,993,646 - Sexton , et al. August 9, 2 | 2011-08-09 |
| Hk1-binding Proteins App 20080213251 - Sexton; Daniel J. ; et al. | 2008-09-04 |
| Endotheliase 2 Ligands App 20080075723 - NIXON; Andrew ; et al. | 2008-03-27 |
| Antibodies that bind hK-1 Grant 7,329,737 - Sexton , et al. February 12, 2 | 2008-02-12 |
| Kunitz Domain Library App 20080020394 - Nixon; Andrew ; et al. | 2008-01-24 |
| Endotheliase-2 Ligands App 20080019962 - Nixon; Andrew ; et al. | 2008-01-24 |
| Endotheliase-2 ligands Grant 7,273,610 - Nixon , et al. September 25, 2 | 2007-09-25 |
| Hot-melt adhesive in particulate form Grant 7,267,878 - Primke , et al. September 11, 2 | 2007-09-11 |
| HK1-binding proteins App 20070004910 - Sexton; Daniel J. ; et al. | 2007-01-04 |
| Endotheliase-2 ligands App 20050180977 - Nixon, Andrew ; et al. | 2005-08-18 |
| Endotheliase-1 ligands App 20050164945 - Nixon, Andrew ; et al. | 2005-07-28 |
| PAPP-A ligands App 20050009136 - Nixon, Andrew ; et al. | 2005-01-13 |
| Kunitz domain library App 20040209243 - Nixon, Andrew ; et al. | 2004-10-21 |
| Construction for routing a conduit for the like through a structural member App 20040145122 - Burguete, Richard ; et al. | 2004-07-29 |
| Hot-melt adhesive in particulate form App 20040143034 - Primke, Hartmut ; et al. | 2004-07-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 